Stockreport

Novo Partnership Fuels Long-Term Optimism for Hims & Hers Health, Inc. (HIMS) [Yahoo! Finance]

Hims & Hers Health, Inc. Class A  (HIMS) 
PDF Hims & Hers Health, Inc. (NYSE:HIMS) with a price target of $30. This reaffirmation comes after the company's launch of Novo Nordisk weight-loss solutions on its platfor [Read more]